Health
Explainer
Common Antidepressant Fluvoxamine Shows Meaningful Benefit for Long COVID Fatigue in Major Trial
5 sources · 22d ago
Sleep Science
AI Model Trained on 65,000 Patients Predicts Risk for 130 Diseases From Single Night of Sleep
6 sources · 22d ago
Diabetes Care
FDA Approves First Once-Weekly Basal Insulin for Type 2 Diabetes
7 sources · 22d ago
More in Health
Pediatric DiabetesTreatment Trade-offs
FDA Approves First Drug to Delay Type 1 Diabetes Progression in Children
Early Intervention Advocates 40%Clinical Safety Monitors 35%Medical Researchers 25%
6 sources · 22d ago
ExplainerCartilage Regeneration
How Single-Injection Therapies Are Regenerating Cartilage in Aging Joints
Regenerative Medicine Researchers 40%Orthopedic Surgeons 30%Healthcare Economists 30%
3 sources · 23d ago
Supplement SafetyExplainer
Common Joint Supplement Glucosamine Linked to Accelerated Alzheimer's Progression
Medical Researchers 40%Clinical Practitioners 35%Patient Advocates 25%
7 sources · 23d ago
Genetic MedicineTreatment Explainer
FDA Approves First Gene Therapy for Congenital Deafness, Restoring Hearing in Children
Clinical Audiologists & ENTs 45%Deaf Community Advocates 30%Medical Geneticists 25%
6 sources · 23d ago
Food SafetyPolicy Shift
FDA Proposes Rule to End 'Self-Affirmed' Food Safety, Mandating Notification for All New Ingredients
Public Health Advocates 40%Food Industry Counsel 35%Federal Regulators 25%
8 sources · 24d ago
Multiple MyelomaExplainer
U.S. FDA Approves Zenbexus, First-in-Class CELMoD Therapy, for Relapsed Multiple Myeloma
Clinical Oncologists 40%Regulatory & Trial Experts 35%Health Economists 25%
8 sources · 24d ago
Menopause CareExplainer
Estrogen-Only Hormone Therapy Linked to 35% Lower Alzheimer's Pathology Risk
Neurology Researchers 40%Women's Health Advocates 30%Clinical Practitioners 30%
6 sources · 24d ago
Gene TherapyClinical Trial
Single-Dose Gene Therapy Slashes LDL Cholesterol by 62% in Landmark Trial
Clinical Researchers 40%Cardiology Patients 30%Medical Safety Regulators 30%
6 sources · 22d ago
Superbug TrackingPublic Health Alert
CDC Warns Multi-Drug Resistant Candida auris Superbug Cases Exceed 3,400 in 27 States
Public Health Officials 40%Infectious Disease Specialists 35%Healthcare Facility Administrators 25%
3 sources · 24d ago
ExplainerNeuromodulation
Personalized, Accelerated TMS Therapy Achieves Depression Remission in Days, Not Months
Clinical Researchers 40%Patient Access Advocates 35%Health Economists 25%
3 sources · 24d ago
Aging BiologyTrial Watch
Landmark $38M Trial Tests Rapamycin and GLP-1 Drugs to Extend Human Healthspan
Geroscience Researchers 40%Clinical Skeptics 30%Public Health Advocates 30%
7 sources · 25d ago
Multiple MyelomaDrug Approval
FDA Approves First-in-Class Cereblon E3 Ligase Modulator for Multiple Myeloma
Clinical Oncologists 40%Patient Advocacy Groups 35%Regulatory Analysts 25%
8 sources · 13d ago















